Schedule 13D ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2019-01-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
814,000
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001762003-19-000003
Form type
SC 13D
Filer
Boston Foundation, Inc.
CIK
CIK 1762003
Filed
Jan 17, 2019
Reporting period
Jan 16, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub